Fight Cat Allergies With Newest Asthma Drug?
Subcutaneous immunotherapy treatment (SCIT) for reducing cat allergy symptoms appeared to be more effective and longer lasting with the help of tezepelumab (Tezspire), a monoclonal antibody recently approved for severe asthma, results from a phase I/II trial suggested. While the randomized CATNIP trial failed to meet its primary endpoint — a difference in total nasal […]
Remote Behavioral Therapy Works for Kids With Tic Disorder
For reducing tic severity in children with Tourette syndrome, an online behavioral therapy worked as well as internet-based education alone and had better participant response, a small randomized trial found. The intervention — 10 weeks of a therapist-supported, internet-delivered exposure and response prevention (ERP) program — was associated with a mean reduction of 6.08 points […]
Meds, surgery may help obesity-related high blood pressure if diet, exercise fall short
Weight-loss medications and surgical procedures show promise for reducing the long-term effects of high blood pressure (also called hypertension) in people who are overweight or have obesity, according to a new American Heart Association scientific statement published today in the Association’s journal Hypertension. A scientific statement is an expert analysis of current research and may […]
Targeting Bacteria in COPD Shows Promise
One study of an immunotherapy for reducing chronic obstructive pulmonary disease (COPD) exacerbations missed its primary endpoint and failed to show a statistically significant benefit even in the subgroup that showed the greatest response. Another study, involving a similar product, showed results so dramatic that an independent expert suspected they were “too good to be […]